KRT19
Keratin, type I cytoskeletal 19
Also known as: CK19, K19, K1C19_HUMAN, K1CS, MGC15366
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08727
- Gene
- KRT19
- Ensembl
- ENSG00000171345
- Chromosome
- 17
- Canonical length
- 400 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Intermediate filaments
OverviewNCBI Gene
The protein encoded by this gene is a member of the keratin family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. Unlike its related family members, this smallest known acidic cytokeratin is not paired with a basic cytokeratin in epithelial cells. It is specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis. The type I cytokeratins are clustered in a region of chromosome 17q12-q21. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
400 residues, UniProt reviewed canonical sequence.
>P08727|KRT19
1 MTSYSYRQSS ATSSFGGLGG GSVRFGPGVA FRAPSIHGGS GGRGVSVSSA RFVSSSSSGA
61 YGGGYGGVLT ASDGLLAGNE KLTMQNLNDR LASYLDKVRA LEAANGELEV KIRDWYQKQG
121 PGPSRDYSHY YTTIQDLRDK ILGATIENSR IVLQIDNARL AADDFRTKFE TEQALRMSVE
181 ADINGLRRVL DELTLARTDL EMQIEGLKEE LAYLKKNHEE EISTLRGQVG GQVSVEVDSA
241 PGTDLAKILS DMRSQYEVMA EQNRKDAEAW FTSRTEELNR EVAGHTEQLQ MSRSEVTDLR
301 RTLQGLEIEL QSQLSMKAAL EDTLAETEAR FGAQLAHIQA LISGIEAQLG DVRADSERQN
361 QEYQRLMDIK SRLEQEIATY RSLLEGQEDH YNNLSASKVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KRT19 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 857 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 857 nTPM
- salivary gland: 772 nTPM
- small intestine: 737 nTPM
- urinary bladder: 730 nTPM
- stomach: 596 nTPM
- colon: 495 nTPM
Single-cell type
- extravillous trophoblasts: 10,172 nCPM
- esophageal apical cells: 8,716 nCPM
- respiratory secretory cells: 8,050 nCPM
- enterocytes: 7,898 nCPM
- urothelial cells: 5,849 nCPM
- colonocytes: 5,384 nCPM
Immune cell
- NK-cell: 0.6 nTPM
- memory CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebellum: 14 nTPM
- midbrain: 4 nTPM
- basal ganglia: 2.5 nTPM
- pons: 2.1 nTPM
- cerebral cortex: 1.5 nTPM
- thalamus: 1.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KRT19.
Disease | ImmuneIEDB
Conditions an epitope on KRT19 was assayed in.
- psoriasis T cell
ReferencesPubMed · IEDB
Publications for KRT19 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
6 publications
- Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma.
2004 · Ann Allergy Asthma Immunol · RCR 0.7 · 25 citations - Increased Circulating Autoantibodies Levels of IgG, IgA, IgM Against Cytokeratin 18 and Cytokeratin 19 in Chronic Obstructive Pulmonary Disease.
2017 · Arch Med Res · RCR 0.7 · 17 citations - Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis.
2001 · Clin Exp Immunol · RCR 0.6 · 23 citations - Identification of nasopharyngeal carcinoma antigens that induce humoral immune response by proteomic analysis.
2007 · Proteomics Clin Appl · RCR 0.2 · 9 citations - Binding of recombinant human cytokeratin 19 to laminin: a possible role in interaction between intermediate filament derived from epithelial cells and extracellular matrixes.
2000 · Cell Struct Funct · RCR 0.2 · 8 citations
Show 1 more
- Circulating autoantibodies in patients with aspirin-intolerant asthma: an epiphenomenon related to airway inflammation.
2006 · J Korean Med Sci · RCR 0.1 · 4 citations
Reference: T cellIEDB
1 publication
- Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells.
2004 · Clin Exp Immunol · RCR 2.6 · 126 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.23
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation involved in embryonic placenta development
- epithelial cell differentiation
- intermediate filament organization
- morphogenesis of an epithelium
- Notch signaling pathway
- response to estrogen
- sarcomere organization
Molecular functions
- protein-containing complex binding
- structural constituent of cytoskeleton
- structural constituent of muscle
- structural constituent of skin epidermis
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KRT19 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KRT19 as an antibody target. Whether an autoantibody or antibody against KRT19 could matter depends on whether native KRT19 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KRT19 is annotated at the cell surface, where native KRT19 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KRT19 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...